Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
Kathryn Lurain(The Ohio State University), Robert Yarchoan(National Cancer Institute), Armando Filie(National Institutes of Health), Elena M. Cornejo Castro(Frederick National Laboratory for Cancer Research), Nazzarena Labò(Frederick National Laboratory for Cancer Research), Denise Whitby(Frederick National Laboratory for Cancer Research), Ralph Mangusan(AIDS United), Wendell Miley(Frederick National Laboratory for Cancer Research), Thomas S. Uldrick(Regeneron (United States)), Vickie Marshall(Leidos (United States)), Romin Roshan(Frederick National Laboratory for Cancer Research), Ramya Ramaswami(National Cancer Institute), Elaine S. Jaffe(National Cancer Institute), Hao‐Wei Wang(Fu Jen Catholic University), Stefania Pittaluga(New York University), Mark J. Roth(National Cancer Institute), Kyle Moore(Frederick National Laboratory for Cancer Research)
Cited by 6
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
|Blood|2011|2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k